NCT04569981 is a NA clinical trial of Climbing in Parkinson Disease, sponsored by Medical University of Vienna.

Who is sponsoring NCT04569981?

NCT04569981 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04569981?

Interventions in NCT04569981: Climbing, Unsupervised activity group.

What condition does NCT04569981 study?

NCT04569981 studies Parkinson Disease.

Is NCT04569981 still recruiting?

NCT04569981 is currently completed. Last updated 30 September 2020.

Last reviewed 2020-09-30 · How we verify

NCT04569981

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sport Climbing With Parkinson's Disease

Completed NA Last updated 30 September 2020

What this trial tests

NA trial testing Climbing in Parkinson Disease in 48 participants. Completed in 29 July 2019.

Timeline

5 June 2018

Primary endpoint
29 July 2019

29 July 2019

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	48
Start date	5 June 2018
Primary completion	29 July 2019
Estimated completion	29 July 2019
Sites	1 location across Austria

Drugs / interventions tested

Climbing
Unsupervised activity group

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Medical University of Vienna

Who can join

18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This controlled interventional study will investigate the effects of a 12-weeks sport climbing course compared to 24 weeks of unsupervised physical exercise on motor symptoms in Parkinson's disease

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson's disease.
Langer A, Hasenauer S, Flotz A, Gassner L, et al · · 2021 · cited 12× · PMID 34112807 · DOI 10.1038/s41531-021-00193-8
Climb up! Head up! Climbing improves posture in Parkinson's disease. A secondary analysis from a randomized controlled trial.
Langer A, Roth D, Santer A, Flotz A, et al · · 2023 · cited 4× · PMID 37157229 · DOI 10.1177/02692155231174990
Vertical locomotion improves horizontal locomotion: effects of climbing on gait and other mobility aspects in Parkinson's disease. A secondary analysis from a randomized controlled trial.
Langer A, Hansen C, Roth D, Santer A, et al · · 2024 · cited 3× · PMID 38678241 · DOI 10.1186/s12984-024-01363-4

Verify or expand the search:

Other trials of Climbing

Trials testing the same drug.

NCT03758599 — Exercise in Anxiety and Posttraumatic Stress Disorders · NA · completed

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04569981 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 30 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04569981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing